Artificial Intelligence (AI) is changing the way we relate to technology and each other. From self-driving cars to the proliferation of chatbots driven by AI to help you buy pretty much anything, AI continues to become a part of our lives.
AI now promises to revolutionalise healthcare. By combining large swaths of genomic data with machine learning algorithms, companies are developing new tools that can predict – and prevent – disease.
Find out about it from the movers and shakers at EmTech Hong Kong this 6-7 June 2017.
Personalised Medicine: Reprogramming the Human Genome with AI
deepCODE: AI in the global platform for genomic data
Hannes co-founded NextCODE Health as an IT spinoff from Iceland’s deCODE genetics, a global leader in analysing and understanding the human genome. He then led the merger of NextCODE with WuXi AppTec’s Genome Center in Shanghai to create WuXi NextCODE which recently attracted investments from Temasek and Jack Ma.
Managing the Digital Life: Integration and Analysis of Multi-Omics Biological Data to Model Human Healthcare
Former chief scientist of BGI - a world leading genome sequencing center - Yingrui cofounded iCarbonX with BGI ex CEO Wang Jun. Their new venture has attained unicorn status in record time, aiming to create an AI health monitoring system able to predict, and prevent, disease. Read more about it in this Nature article.
…And that’s not it. CRISPR Cas-9 leading scientists will speak at EmTech Hong Kong, including Korean genome editing powerhouse ToolGen, Broad Institute of MIT and Harvard, and Agenovir Corp.